Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 390

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?

Olanow, C. Warren, Brundin, Patrik·2013·Movement Disorders

Abstract

Altered protein handling is thought to play a key role in the etiopathogenesis of Parkinson's disease (PD), as the disorder is characterized neuropathologically by the accumulation of intraneuronal protein aggregates (Lewy bodies and Lewy neurites). Attention has particularly focused on the α‐synuclein protein, as it is the principal component of Lewy pathology. Moreover, point mutations in the α‐synuclein gene cause rare familial forms of PD. Importantly, duplication/triplication of the wild type α‐synuclein gene also cause a form of PD, indicating that increased levels of the normal α‐synuclein protein is sufficient to cause the disease. Further, single nucleotide polymorphisms in the α‐synuclein gene are associated with an increased risk of developing sporadic PD. Recent evidence now suggests the possibility that α‐synuclein is a prion‐like protein and that PD is a prion‐like disease. Within cells, α‐synuclein normally adopts an α‐helical conformation. However, under certain circumstances, the protein can undergo a profound conformational transition to a β‐sheet–rich structure that polymerizes to form toxic oligomers and amyloid plaques. Recent autopsy studies of patients with advanced PD who received transplantation of fetal nigral mesencephalic cells more than a decade earlier demonstrated that typical Lewy pathology had developed within grafted neurons. This suggests that α‐synuclein in an aberrantly folded, β‐sheet–rich form had migrated from affected to unaffected neurons. Laboratory studies confirm that α‐synuclein can transfer from affected to unaffected nerve cells, where it appears that the misfolded protein can act as a template to promote misfolding of host α‐synuclein. This leads to the formation of larger aggregates, neuronal dysfunction, and neurodegeneration. Indeed, recent reports demonstrate that a single intracerebral inoculation of misfolded α‐synuclein can induce Lewy‐like pathology in cells that can spread from affected to unaffected regions and can induce neurodegeneration with motor disturbances in both transgenic and normal mice. Further, inoculates derived from the brains of elderly α‐synuclein–overexpressing transgenic mice have now been shown to accelerate the disease process when injected into the brains of young transgenic animals. Collectively, these findings support the hypothesis that α‐synuclein is a prion‐like protein that can adopt a self‐propagating conformation that causes neurodegeneration. We propose that this mechanism plays an important role in the development of PD and provides novel targets for candidate neuroprotective therapies. © 2013 Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.25373

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Cited by

See all 390

Metadata

Authors
Olanow, C. W., & Brundin, P.
Venue
Movement Disorders
Publisher
Wiley
Published
2013-01
Volume
28
Issue
1
Pages
31-40
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W1851334881
Cited by
390
References
69
FWCI
24.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder? https://app.cochat.ai/papers/10.1002/mds.25373
The paper
Olanow, C. W., & Brundin, P. (2013). Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder? Movement Disorders. https://doi.org/10.1002/mds.25373

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.